Universal Biosensors (ASX:UBI) Days Sales Outstanding : 55.45 (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Days Sales Outstanding?

Universal Biosensors's average Accounts Receivable for the three months ended in Mar. 2025 was A$0.95 Mil. Universal Biosensors's Revenue for the three months ended in Mar. 2025 was A$1.56 Mil. Hence, Universal Biosensors's Days Sales Outstanding for the three months ended in Mar. 2025 was 55.45.

The historical rank and industry rank for Universal Biosensors's Days Sales Outstanding or its related term are showing as below:

ASX:UBI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.83 Med: 76.6 Max: 1331.69
Current: 83.46

During the past 13 years, Universal Biosensors's highest Days Sales Outstanding was 1331.69. The lowest was 10.83. And the median was 76.60.

ASX:UBI's Days Sales Outstanding is ranked worse than
66.79% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.94 vs ASX:UBI: 83.46

Universal Biosensors's Days Sales Outstanding declined from Mar. 2024 (138.52) to Mar. 2025 (55.45).

Universal Biosensors Days Sales Outstanding Historical Data

The historical data trend for Universal Biosensors's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Days Sales Outstanding Chart

Universal Biosensors Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

10.83

17.34

58.48

85.29

89.55

Universal Biosensors Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															138.52	104.72	74.66	90.39	55.45

Competitive Comparison of Universal Biosensors's Days Sales Outstanding

For the Medical Devices subindustry, Universal Biosensors's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Biosensors's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Universal Biosensors Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Universal Biosensors's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (2.126	+	0.957)	/	2 )	/	6.283	*	365
=	1.5415					/	6.283	*	365
=	89.55

Universal Biosensors's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0.957	+	0.933)	/	2 )	/	1.555	*	365 / 4
=	0.945					/	1.555	*	365 / 4
=	55.45

Universal Biosensors (ASX:UBI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Universal Biosensors Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Biosensors Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Corporate Avenue, Rowville, VIC, AUS, 3178

Website

https://www.universalbiosensors.com

Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.

Universal Biosensors Headlines

No Headlines